Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tamoxifen”

345 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 345 results

Large-scale testing (Phase 3)UnknownNCT01352091
What this trial is testing

Adjuvant AI Combined With Zoladex

Who this might be right for
Breast Cancer
Fudan University 670
Testing effectiveness (Phase 2)UnknownNCT01266213
What this trial is testing

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

Who this might be right for
Metastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal
Samsung Medical Center 147
Testing effectiveness (Phase 2)Ended earlyNCT02322853
What this trial is testing

Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors

Who this might be right for
PostmenopausalMetastatic Breast Cancer
Centre Francois Baclesse 8
Not applicableStudy completedNCT00727883
What this trial is testing

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

Who this might be right for
Breast Cancer
AstraZeneca 190
Not applicableUnknownNCT04891731
What this trial is testing

Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer

Who this might be right for
Hormone Receptor-positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Not applicableStudy completedNCT00228930
What this trial is testing

Tamoxifen Pharmacogenetics and Clinical Effects

Who this might be right for
Breast Cancer
National Institute of General Medical Sciences (NIGMS) 297
Large-scale testing (Phase 3)Ended earlyNCT00016341
What this trial is testing

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Not applicableUnknownNCT03504631
What this trial is testing

Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen

Who this might be right for
Breast Cancer Female
Trisakti University 117
Post-approval studies (Phase 4)UnknownNCT02690870
What this trial is testing

Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF

Who this might be right for
Infertility
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 210
Testing effectiveness (Phase 2)Ended earlyNCT02395627
What this trial is testing

Reversing Therapy Resistance With Epigenetic-Immune Modification

Who this might be right for
Breast Neoplasms
University of California, San Francisco 38
Testing effectiveness (Phase 2)UnknownNCT00492505
What this trial is testing

Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 200
Large-scale testing (Phase 3)UnknownNCT00002460
What this trial is testing

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK
Large-scale testing (Phase 3)Study completedNCT00002967
What this trial is testing

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc
Testing effectiveness (Phase 2)Study completedNCT02584465
What this trial is testing

REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression

Who this might be right for
Ovarian Carcinoma
ARCAGY/ GINECO GROUP 68
Post-approval studies (Phase 4)Study completedNCT02070692
What this trial is testing

Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users

Who this might be right for
Menstruation Disturbances
Oregon Health and Science University 56
Testing effectiveness (Phase 2)Study completedNCT03870399
What this trial is testing

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

Who this might be right for
Neuroendocrine TumorsProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor
AC Camargo Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT03354039
What this trial is testing

Tamoxifen in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
University Hospital, Basel, Switzerland 93
Early research (Phase 1)Study completedNCT02586675
What this trial is testing

TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer

Who this might be right for
Breast CancerBreast Cancer - FemaleBreast Cancer - Male
H. Lee Moffitt Cancer Center and Research Institute 7
Testing effectiveness (Phase 2)Study completedNCT03931928
What this trial is testing

Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients

Who this might be right for
Breast CancerDCIS
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) 356
Testing effectiveness (Phase 2)Study completedNCT02166944
What this trial is testing

Tamoxifen Treatment in Patients With Motor Neuron Disease

Who this might be right for
Amyotrophic Lateral SclerosisALS Functional Ration ScaleTAR-DNA-binding Protein-43+2 more
Taipei Medical University Shuang Ho Hospital 20
Load More Results